Genmab Fair Value
GE
The fair market value of GE9.MU stock is 396.9 EUR. Relative to the market price of 0 EUR Genmab is undervalued by 90.5%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Genmab Valuation
The fair value level of 396.9 EUR can be considered as an effective entry point for long-term investors to start investing in GE9.MU stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
GE9.MU stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Genmab A/S Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
61.68
2
Median P/E over 5 years
35.5
3
Minimum P/E over 5 years
25.45
4
Earning per share (last 12 months)
83.24 DKK
Maximum value
1
x
4
=
689.54 EUR
Fair value
2
x
4
=
396.9 EUR
Minimum value
3
x
4
=
284.52 EUR
Genmab A/S price metrics
1.15
Annual return (geometric mean)
31.88
Risk (standard deviation) of returns
β
0.05
Beta (volatility compared to market)